Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P2MF
|
|||
| Drug Name |
N91115
|
|||
| Synonyms |
Cavosonstat; UNII-O2Z8Q22ZE4; O2Z8Q22ZE4; Cavosonstat [USAN]; Cavosonstat (USAN); 1371587-51-7; 3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid; SCHEMBL1289569; CHEMBL3989910; BXSZILNGNMDGSL-UHFFFAOYSA-N; AKOS030527843; D10916; N-91115; 3-Chloro-4-(6-hydroxy-2-quinolinyl)benzoic acid; Benzoic acid, 3-chloro-4-(6-hydroxy-2-quinolinyl)-
Click to Show/Hide
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Phase 2 | [1] | |
| Company |
Nivalis Therapeutics Boulder, CO
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H10ClNO3
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O
|
|||
| InChI |
1S/C16H10ClNO3/c17-13-8-10(16(20)21)1-4-12(13)15-5-2-9-7-11(19)3-6-14(9)18-15/h1-8,19H,(H,20,21)
|
|||
| InChIKey |
BXSZILNGNMDGSL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1371587-51-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.